Fetomaternal outcomes in pregnant women with congenital heart disease: a comparative analysis from an apex institute
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Objective With advancements in cardiac surgical interventions during infancy and childhood, the incidence of maternal congenital heart disease (CHD) is increasing. This retrospective study compared fetal and cardiac outcomes in women with and without CHD, along with a sub-analysis between cyanotic versus non-cyanotic defects and operated versus non-operated cases.Methods A 10-year data were retrospectively collected from pregnant women with CHD and a 1:1 ratio of pregnant women without any heart disease. Adverse fetal and cardiac outcomes were noted in both groups. Statistical significance was set at <i>P</i><0.05.Results A total of 86 pregnant women with CHD were studied, with atrial septal defects (29.06%) being the most common. Out of 86 participants, 27 (31.39%) had cyanotic CHD. Around 55% of cases were already operated on for their cardiac defects. Among cardiovascular complications, 5.8% suffered from heart failure, 7.0% had pulmonary arterial hypertension, 8.1% presented in New York Heart Association functional class IV, 9.3% had a need for intensive care unit admission, and one experienced maternal mortality. Adverse fetal outcomes, including operative vaginal delivery, mean duration of hospital stay, fetal growth restriction, preterm birth (<37 weeks), low birth weight (<2,500 g), 5-minute APGAR score <7, and neonatal intensive care unit admissions, were significantly higher in women with CHD than in women without heart disease.Conclusion Women with CHD have a higher risk of adverse fetal and cardiac outcomes. The outcome can be improved with proper pre-conceptional optimization of the cardiac condition, good antenatal care, and multidisciplinary team management.
Abstract
Objective With advancements in cardiac surgical interventions during infancy and childhood, the incidence of maternal congenital heart disease (CHD) is increasing. This retrospective study compared fetal and cardiac outcomes in women with and without CHD, along with a sub-analysis between cyanotic versus non-cyanotic defects and operated versus non-operated cases. Methods A 10-year data were retrospectively collected from pregnant women with CHD and a 1:1 ratio of pregnant women without any heart disease. Adverse fetal and cardiac outcomes were noted in both groups. Statistical significance was set at P<0.05. Results A total of 86 pregnant women with CHD were studied, with atrial septal defects (29.06%) being the most common. Out of 86 participants, 27 (31.39%) had cyanotic CHD. Around 55% of cases were already operated on for their cardiac defects. Among cardiovascular complications, 5.8% suffered from heart failure, 7.0% had pulmonary arterial hypertension, 8.1% presented in New York Heart Association functional class IV, 9.3% had a need for intensive care unit admission, and one experienced maternal mortality. Adverse fetal outcomes, including operative vaginal delivery, mean duration of hospital stay, fetal growth restriction, preterm birth (<37 weeks), low birth weight (<2,500 g), 5-minute APGAR score <7, and neonatal intensive care unit admissions, were significantly higher in women with CHD than in women without heart disease. Conclusion Women with CHD have a higher risk of adverse fetal and cardiac outcomes. The outcome can be improved with proper pre-conceptional optimization of the cardiac condition, good antenatal care, and multidisciplinary team management.
참고문헌 (24)
- Meh C, "Trends in maternal mortality in India over two decades in nationally representative surveys", BJOG, 129, pp.550~561 (2022)
- Hettiarachchi A, "Heart disease complicating pregnancy as a leading cause of maternal deaths in LMIC settings : the Sri Lankan experience", Lancet Reg Health Southeast Asia, 15, pp.100223~ (2023)
- Regitz-Zagrosek V, "2018 ESC guidelines for the management of cardiovascular diseases during pregnancy", Eur Heart J, 39, pp.3165~3241 (2018)
- Opotowsky AR, "Maternal cardiovascular events during childbirth among women with congenital heart disease", Heart, 98, pp.145~151 (2012)
- Thompson JL, "Medical and obstetric outcomes among pregnant women with congenital heart disease", Obstet Gynecol, 126, pp.346~354 (2015)
- Krieger EV, "Comparison of risk of hypertensive complications of pregnancy among women with versus without coarctation of the aorta", Am J Cardiol, 107, pp.1529~1534 (2011)
- Hayward RM, "Maternal and fetal outcomes of admission for delivery in women with congenital heart disease", JAMA Cardiol, 2, pp.664~671 (2017)
- Lima FV, "National trends and in-hospital outcomes in pregnant women with heart disease in the United States", Am J Cardiol, 119, pp.1694~1700 (2017)
- Josefsson A, "Reproductive patterns and pregnancy outcomes in women with congenital heart disease--a Swedish populationbased study", Acta Obstet Gynecol Scand, 90, pp.659~665 (2011)
- Karamlou T, "A growing problem : maternal death and peripartum complications are higher in women with grown-up congenital heart disease", Ann Thorac Surg, 92, pp.2193~2198 (2011)
- Pieper PG, "Uteroplacental blood flow, cardiac function, and pregnancy outcome in women with congenital heart disease", Circulation, 128, pp.2478~2487 (2013)
- Roos-Hesselink J, "Pregnancy outcomes in women with cardiovascular disease : evolving trends over 10 years in the ESC registry of pregnancy and cardiac disease(ROPAC)", Eur Heart J, 40, pp.3848~3855 (2019)
- Drenthen W, "Predictors of pregnancy complications in women with congenital heart disease", Eur Heart J, 31, pp.2124~2132 (2010)
- Silversides CK, "Pregnancy outcomes in women with heart disease : the CARPREG II study", J Am Coll Cardiol, 71, pp.2419~2430 (2018)
- Ramlakhan KP, "Congenital heart disease in the ESC EORP registry of pregnancy and cardiac disease(ROPAC)", IJCCHD, 3, pp.100107~ (2021)
- Ramage K, "Association of adult congenital heart disease with pregnancy, maternal, and neonatal outcomes", JAMA Netw Open, 2, pp.e193667~ (2019)
- Schlichting LE, "Maternal comorbidities and complications of delivery in pregnant women with congenital heart disease", J Am Coll Cardiol, 73, pp.2181~2191 (2019)
- Liu Y, "Pregnancy complications and outcomes among women with congenital heart disease in Beijing, China", Front Cardiovasc Med, 8, pp.765004~ (2022)
- Takatsuki S, "Pregnancy and delivery in patients with repaired congenital heart disease-a retrospective Japanese multicenter study", Circ J, 84, pp.2270~2274 (2020)
- Ladouceur M, "How pregnancy impacts adult cyanotic congenital heart disease : a multicenter observational study", Circulation, 135, pp.2444~2447 (2017)
- Thorne S, "Risks of contraception and pregnancy in heart disease", Heart, 92, pp.1520~1525 (2006)
- van der Bom T, "Contemporary survival of adults with congenital heart disease", Heart, 101, pp.1989~1995 (2015)
- Chawanpaiboon S, "Global, regional, and national estimates of levels of preterm birth in 2014 : a systematic review and modelling analysis", Lancet Glob Health, 7, pp.e37~e46 (2019)
- Yadav V, "Maternal and fetal outcome in operated vs non-operated cases of congenital heart disease cases in pregnancy", Indian Heart J, 70, pp.82~86 (2018)